Nalpropion Pharmaceuticals is a biopharmaceutical company focused on the treatment of weight loss.
|Title||Application Date||Patent Date||Status
(Patent / Application)
|Compositions and methods for reducing major adverse cardiovascular events||Mar 18, 2019||Nov 17, 2020||Patent|
|Compositions and methods for weight loss in at risk patient populations||Mar 18, 2019||Nov 10, 2020||Patent|
|Methods of treating overweight and obesity||Apr 19, 2017||Sep 03, 2019||Patent|
|Methods of providing weight loss therapy in patients with major depression||Jan 29, 2016||Jun 18, 2019||Patent|
|Methods for administering weight loss medications||Aug 13, 2018||Jun 04, 2019||Patent|